EPA:ABLD - Euronext Paris - Matif - FR001400AHX6 - Common Stock - Currency: EUR
EPA:ABLD (5/23/2025, 7:00:00 PM)
5.4
0 (0%)
The current stock price of ABLD.PA is 5.4 EUR. In the past month the price decreased by -1.82%. In the past year, price increased by 77.63%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
BNR.DE | BRENNTAG SE | 15.47 | 8.20B | ||
RXL.PA | REXEL SA | 21.75 | 7.35B | ||
IMCD.AS | IMCD NV | 32.55 | 7.04B | ||
AZE.BR | AZELIS GROUP NV | 12.63 | 3.48B | ||
BYW.DE | BAYWA AG | N/A | 720.79M | ||
THEP.PA | THERMADOR GROUPE | 14.92 | 635.72M | ||
KCO.DE | KLOECKNER & CO SE | N/A | 624.43M | ||
JCQ.PA | JACQUET METALS SA | 46.74 | 442.60M | ||
BYW6.DE | BAYWA-BAYERISCHE WARENVERMIT | N/A | 294.10M | ||
HMU.DE | HMS BERGBAU AG | 10.68 | 136.78M | ||
WOLF.DE | META WOLF AG | N/A | 75.73M | ||
ALHRG.PA | HERIGE | 6.13 | 68.17M |
ABL Diagnostics SA engages in owning and renting railcars for rail freight transportation. The company is headquartered in Suresnes, Ile-De-France and currently employs 17 full-time employees. The firm also provides Commercial and Industrial Machinery and Equipment Rental and Leasing services.
ABL DIAGNOSTICS
40 boulevard Henri Sellie
Suresnes ILE-DE-FRANCE FR
Employees: 17
Phone: 33145061574
The current stock price of ABLD.PA is 5.4 EUR.
The exchange symbol of ABL DIAGNOSTICS is ABLD and it is listed on the Euronext Paris - Matif exchange.
ABLD.PA stock is listed on the Euronext Paris - Matif exchange.
7 analysts have analysed ABLD.PA and the average price target is 6.28 EUR. This implies a price increase of 16.36% is expected in the next year compared to the current price of 5.4. Check the ABL DIAGNOSTICS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ABL DIAGNOSTICS (ABLD.PA) has a market capitalization of 86.99M EUR. This makes ABLD.PA a Micro Cap stock.
ABL DIAGNOSTICS (ABLD.PA) currently has 17 employees.
ABL DIAGNOSTICS (ABLD.PA) has a support level at 5.39 and a resistance level at 5.45. Check the full technical report for a detailed analysis of ABLD.PA support and resistance levels.
The Revenue of ABL DIAGNOSTICS (ABLD.PA) is expected to grow by 15.22% in the next year. Check the estimates tab for more information on the ABLD.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ABL DIAGNOSTICS (ABLD.PA) has a dividend yield of 0.92%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of ABLD.PA dividend history, reliability and sustainability.
The PE ratio for ABL DIAGNOSTICS (ABLD.PA) is 540. This is based on the reported non-GAAP earnings per share of 0.01 and the current share price of 5.4 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ABLD.PA.
ChartMill assigns a technical rating of 4 / 10 to ABLD.PA. When comparing the yearly performance of all stocks, ABLD.PA is one of the better performing stocks in the market, outperforming 96.91% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to ABLD.PA. ABLD.PA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months ABLD.PA reported a non-GAAP Earnings per Share(EPS) of 0.01. The EPS decreased by -70.74% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 3.13% | ||
ROA | 1.36% | ||
ROE | 2.7% | ||
Debt/Equity | 0.26 |
ChartMill assigns a Buy % Consensus number of 86% to ABLD.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 800% and a revenue growth 15.22% for ABLD.PA